Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

156520

registered interest
date	19/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Campylobacter
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will consider further action to encourage supermarkets to provide more information to customers about the campylobacter contamination rates of chickens sold.
tabling member printed	Lord Condon
uin	HL2943
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Supermarkets do not provide this information to customers. The Food Standards Agency (FSA) is publishing quarterly results from its year-long retail survey of campylobacter on whole fresh chickens in order to further drive the implementation of poultry production methods that reduce campylobacter throughout the supply chain. The prime objective is to lower the levels of campylobacter on chickens so that there is minimal risk to consumers.</p><p> </p><p> </p><p> </p><p>In addition, through Food Safety Week 2014, the FSA has successfully focused on the message about safe handling of raw poultry which has had widespread coverage in the media. The FSA intends to periodically reinforce the messages to consumers to minimise the risk from cross-contamination by handling raw chicken carefully and to avoid washing it. The FSA has also worked closely with retailers so that the ‘Do not wash’ message is now being rolled out across all poultry packaging at retail.</p><p> </p> answering member printed Earl Howe question first answered 03/12/2014 15:46:58 answering member 2000 label Biography information for Earl Howe
tabling member	2171 label Biography information for Lord Condon

156521

registered interest
date	19/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the future wellbeing of severely disabled adults living in care homes that are due to be closed.
tabling member printed	Lord Lexden
uin	HL2944
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>The Government has made no such assessment. Local authorities are responsible for assessing the social care needs of their populations and for arranging or providing care to meet their eligible needs.</p><p> </p><p> </p><p> </p><p>Should care homes have to close, it is for the relevant local authorities to assess the care needs of residents and ensure that suitable alternative provision is arranged for them if they are not able to do so for themselves.</p><p> </p><p><strong> </strong></p><p> </p><p>The Government is committed to improving outcomes for disabled people and supporting them to live independent lives. <em>Fulfilling Potential</em>, the Government’s Disability Strategy sets out to achieve our ambition of enabling disabled people – of all backgrounds and ages - to fulfil their potential and play a full role in society.</p><p> </p> answering member printed Earl Howe question first answered 27/11/2014 12:46:30 answering member 2000 label Biography information for Earl Howe
tabling member	4202 label Biography information for Lord Lexden

156522

registered interest
date	19/11/2014
answering body	Leader of the House of Lords
answering dept id	92
answering dept short name
answering dept sort name	Leader of the House of Lords
hansard heading	Written Questions
house id	2
legislature	25277 pref label House of Lords
question text	To ask the Leader of the House what steps she takes to ensure the quality of answers to parliamentary questions; and what assessment she has made of the length of time taken to provide them.
tabling member printed	Lord Laird
uin	HL2945
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>It is the responsibility of individual ministers to decide what answers they give to Questions for Written Answer (QWAs), and they are of course accountable to the House for those answers. That direct accountability is important: that is why Ministers in this House must provide personally signed answers to members. The Ministerial Code states that <em>“It is of paramount importance that Ministers give accurate and truthful information to Parliament”.<br><br></em>As Leader of the House I have a particular responsibility to encourage Ministers and their departments to be punctual in answering written questions. My office immediately approach departments who have not responded to questions after 10 working days, and remain in contact with them until the questions are answered. At the end of this Session I will publish data on the annual performance of departments on their promptness in dealing with QWAs.</p><p> </p> answering member printed Baroness Stowell of Beeston question first answered 03/12/2014 12:49:49 answering member 4205 label Biography information for Baroness Stowell of Beeston
tabling member	2479 label Biography information for Lord Laird

156455

registered interest
date	18/11/2014
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Sudan
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the ability of the United Nations Mission in Darfur to conduct a thorough investigation of reported mass rapes in Tabit during their visit on 4 November, in the light of the interruption of that visit by military intelligence personnel.
tabling member printed	Lord Avebury
uin	HL2897
answer	answer is ministerial correction date of answer 27/11/2014 answer text The refusal to allow the UN African Union Mission in Darfur (UNAMID) access to Tabit on 4 November prevented them from conducting a thorough investigation in to the very serious allegations of mass rapes. Some access was subsequently possible on 9 November but we continue to call on the Government of Sudan to allow UNAMID full and unhindered access to Tabit. answering member printed Baroness Anelay of St Johns question first answered 27/11/2014 14:54:53 answering member 3474 label Biography information for Baroness Anelay of St Johns
tabling member	1665 label Biography information for Lord Avebury

156456

registered interest
date	18/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Falkland Islands
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will revisit the circumstances in which the late Corporal McLaughlin was recommended for a gallantry award during the Falklands conflict which was subsequently withdrawn; and if not, why not.
tabling member printed	Lord Ashcroft
uin	HL2898
answer	answer is ministerial correction date of answer 01/12/2014 answer text <p>The noble lord will be aware of the hon. Member for Wallasey’s (Ms Eagle) Westminster Hall debate on 18 November about posthumous recognition for Corporal McLaughlin. Following the debate, the Minister of State for Defence, Personnel, Welfare and Veterans (Anna Soubry) and I have agreed that while a formal investigation is not an option, I will re-examine the facts surrounding recognition in this case. However, to be clear, no citation for an award was received for consideration by the Ministry of Defence and therefore it would be incorrect to say that Cpl McLaughlin had a recommendation withdrawn. The issue is that no citation was actually submitted for consideration by the Operational Awards Committee; a fact that is acknowledged by all parties.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member printed Lord Astor of Hever question first answered 01/12/2014 16:19:25 answering member 3428 label Biography information for Lord Astor of Hever attachment 1 file name Debate Corporal Stewart Mclaughlin 18 November 2014.doc title DebateHansard Extract 18 November 2014
tabling member	2568 label Biography information for Lord Ashcroft

156457

registered interest
date	18/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment the Medicines and Healthcare Products Regulatory Agency and the Advisory Committee for Malaria Prevention have made of the United States Food and Drug Administration's Safety Communication of 29 July 2013 warning of the risk of psychiatric and nerve side effects from taking Lariam (mefloquine) as a malaria prophylactic.
tabling member printed	Baroness Corston
uin	HL2899
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>Mefloquine (brand name Lariam) is one of several drugs licensed for the prevention (<strong>c</strong>hemoprophylaxis) or treatment of malaria. As with any medicine, mefloquine may cause side effects in some people and the potential risks should be balanced against the expected benefits of therapy. Information on possible side effects is available to the medical profession via the Summary of Product Characteristics (SmPC), and to patients via the Patient Information Leaflet.</p><p> </p><p> </p><p> </p><p>In 2013, the Medicines and Healthcare products Regulatory Agency (MHRA) strengthened the warnings in the mefloquine SmPC, particularly regarding the well-established risk of neuropsychiatric side effects. The licence holder (Roche) also issued a letter to healthcare professionals at the end of October 2013 to increase awareness of these possible risks, alongside a prescriber checklist and patient alert card to aid compliance with the warnings. In November 2013, the MHRA issued a further communication to healthcare professionals on the risks of mefloquine via its Drug Safety Update bulletin:</p><p> </p><p> </p><p> </p><p>www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON336723</p><p> </p><p> </p><p> </p><p>As with all medicines, the MHRA will keep the safety of mefloquine under continual review.</p><p> </p><p> </p><p> </p><p>The Advisory Committee for Malaria Prevention (ACMP) carefully considered all available data following the Food and Drug Administration’s safety communication and subsequent modification of the SmPC by Roche in September 2013. SmPC recommendations for monitoring of liver function and eye assessment in long term use have also been added to the guidelines. The ACMP continues to believe that mefloquine is a valuable option for prophylaxis against malaria when appropriate risk assessments are undertaken.</p><p> </p> answering member printed Earl Howe question first answered 02/12/2014 12:38:24 answering member 2000 label Biography information for Earl Howe
tabling member	215 label Biography information for Baroness Corston

156458

registered interest
date	18/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many serving (1) members of the armed forces, and (2) reservists, deployed to Sierra Leone in the ebola epidemic have been given Lariam (mefloquine) as a malaria prophylaxis.
tabling member printed	Baroness Corston
uin	HL2900
answer	answer is ministerial correction date of answer 01/12/2014 answer text <p>58 UK Armed Forces personnel who have been deployed on Operation GRITROCK before 31 October 2014 have been prescribed Mefloquine (commercially known as Lariam) as a malaria prophylaxis. All of these 58 were Regulars.</p><p> </p><p>The exact choice of antimalarial drug used by the military depends on a number of factors, including the region the individual is deploying to, their health and any past history of side effects. Malarone is the first choice drug for those Service personnel deploying on Operation GRITROCK. For those individuals unable to tolerate Malarone the second choice is Mefloquine. Doxycycline will be offered to those individuals who cannot tolerate Malorone or Mefloquine.</p><p> </p><p> </p> answering member printed Lord Astor of Hever question first answered 01/12/2014 16:13:10 answering member 3428 label Biography information for Lord Astor of Hever
tabling member	215 label Biography information for Baroness Corston

156459

registered interest
date	18/11/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Mefloquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether Lariam (mefloquine) is administered to pilots and air crew serving in the armed forces.
tabling member printed	Baroness Corston
uin	HL2901
answer	answer is ministerial correction date of answer 01/12/2014 answer text <p>As with all prescriptions the Ministry of Defence follows the drug manufacturer's advice which stipulates that Mefloquine (commercially known as Lariam) should not be taken if you are carrying out complex tasks such as driving, piloting an aircraft or diving. Accordingly, the Department's current policy is that aircrew are not to take Mefloquine.</p> answering member printed Lord Astor of Hever question first answered 01/12/2014 16:16:54 answering member 3428 label Biography information for Lord Astor of Hever
tabling member	215 label Biography information for Baroness Corston

156460

registered interest
date	18/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Malaria
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the unit cost is of (1) Lariam (mefloquine), and (2) malarone.
tabling member printed	Baroness Corston
uin	HL2902
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>The current edition of the British National Formulary lists the price of Lariam (mefloquine) as £14.53 for a pack of 8 tablets and the price of Malarone (proguanil hydrochloride with atovaquone) as £25.21 for a pack of 12 tablets.</p><p> </p> answering member printed Earl Howe question first answered 02/12/2014 12:37:24 answering member 2000 label Biography information for Earl Howe
tabling member	215 label Biography information for Baroness Corston

156461

registered interest
date	18/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Malaria
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government on how many occasions the Advisory Committee for Malaria Prevention has met in the last two years.
tabling member printed	Baroness Corston
uin	HL2903
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>Full meetings of the Advisory Committee for Malaria Prevention occurred in March and August of 2012 and January and December of 2013. The next full meeting is planned for January 2015. There was a sub-group meeting in 2014 to approve the 2014 version of the <em>Guidelines for malaria prevention in travellers from the UK</em>.</p><p> </p> answering member printed Earl Howe question first answered 02/12/2014 12:41:24 answering member 2000 label Biography information for Earl Howe
tabling member	215 label Biography information for Baroness Corston